Orrick, Herrington & Sutcliffe advised the previous majority shareholders of Hager & Meisinger on the sale of a controlling stake to the European private equity investor Apheon, the firm announced. Hager & Meisinger, headquartered in Neuss, is a provider of premium dental instruments and workflow solutions.

The Orrick team was led by Munich private equity partner Dr. Christoph Brenner and managing associate Maria Teodorescu (both M&A and Private Equity, Munich). It included Dr. Stefan Renner (Partner, M&A and Private Equity, Düsseldorf), Adrian Dengler (Counsel, M&A and Private Equity, Munich), Dr. Stefan Schultes-Schnitzlein (Partner, Tax, Düsseldorf), Carsten Engelings (Counsel, Tax, Düsseldorf), Dr. Lars Mesenbrink (Partner, Antitrust, Competition and Investment Law, Düsseldorf), Dr. Benedikt Kamann (Managing Associate, Antitrust, Competition and Investment Law, Düsseldorf), Dr. André Zimmermann (Partner, Employment, Düsseldorf) and Marianna Urban (Counsel, Employment, Düsseldorf).

According to the announcement, Apheon will work with the previous shareholders and co-CEOs of Hager & Meisinger, Dr. Burkard Höchst and Sebastian Voss, who both retain significant stakes. The group plans to grow organically and through acquisitions, with a focus on expanding its presence in the United States and strengthening its international sales reach.

Founded in 1888, Hager & Meisinger combines the Meisinger and Jota brands and supplies dentists in more than 100 countries, with manufacturing in Neuss and Rüthi, Switzerland. Apheon, founded in 2005, has raised more than EUR 5 billion in capital.

For detailed information, as well as the picture copyright, please see the law firm’s original article here: https://www.orrick.com/de-DE/News/2026/10/Controlling-Stake-in-Hager-and-Meisinger-Acquired-by-Private-Equity-Firm-Apheon